The Law Offices of Todd M. Garber announces that it is investigating
potential claims on behalf of investors of Edwards Lifesciences
Corporation (“Edwards Lifesciences” or the “Company”) (NYSE:EW),
concerning possible violations of federal securities laws. The
investigation focuses on certain statements issued by the Company
between April 25, 2012 and April 23, 2013.
Edwards Lifesciences is a medical device maker that designs and markets,
among other things, artificial heart valves for implantation in patients
with advanced cardiovascular disease. The Company offers a range of such
valves, including both valves that require traditional open-chest
surgery, and its newer SAPIEN line of transcatheter heart valves
(“THVs”), which may be implanted using a minimally invasive procedure.
The investigation is related to allegations that the Company issued
false and/or misleading statements and failed to disclose material facts
related to the prospects, projected sales and adoption of the Company’s
Edwards SAPIEN transcatheter aortic heart valve, including the related
transfemoral and transapical delivery methods (“SAPIEN”), and related
projections of financial performance for the Company’s operations.
On April 23, 2013, the Company disclosed that approximately 20 candidate
hospitals had postponed SAPIEN training, that there was substantially no
backlog of patients awaiting SAPIEN implants, and that the Company’s
financial results had been and would likely continue to be weaker than
estimates. In response to this news, Edwards Lifesciences’ stock price
fell $18.21 per share, or 21.99 percent, to close at $64.60 per share on
April 24, 2013 on extremely heavy trading volume.
If you purchased Edwards Lifesciences common stock during the foregoing
period, if you have information or would like to learn more, or if you
have any questions concerning this announcement or your rights or
interests with respect to these matters, please contact Todd M. Garber,
Esquire, of the Law Offices of Todd M. Garber, by telephone at
213-700-7262 or by email to info@toddgarberlaw.com.
This press release may be considered Attorney Advertising in some
jurisdictions under the applicable law and ethical rules.
Copyright Business Wire 2013